SEC Form 4 · accession 0001179110-15-016396
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
August J Moretti
Officer — Chief Financial Officer & SVP
Period of report
Dec 16, 2015
Accepted (ET)
Dec 17, 2015 · 12:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 16, 2015 | M | 5,000 | $5.35 | A | 26,319 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $5.35 | Dec 16, 2015 | M | 5,000 | D | — | Jan 3, 2022 | Common Stock | 5,000 | 192,500 | D |
Explanation of responses
- F1200,000 stock options were granted on 01/3/2012 and were exercisable on January 3rd, 2013 with respect to 25% of the underlying shares and in equal monthly installments for the 36 months thereafter. The stock options exercised on December 16, 2015 were Incentive Stock Options (ISOs).